Deutsche Bank has published a report on TrueBlue TBI reiterating their rating after the appearance of rising revenues.
In the report, Deutsche Bank wrote, "Mgmt expects the rev acceleration seen in June will continue into 3Q, which was a nice surprise. Our 3QE EPS goes up from $0.28 to $0.30 (prior Street $0.30), 4QE goes from $0.17 to $0.22 (prior Street $0.17), '11E increases from $0.65 to $0.74 (prior Street at $0.68) and '12E moves from $1.02 to $1.03 (prior Street $1.02). Our PT remains $18 or 18x our '12E EPS. We reiterate our Buy on TBI due to market share gains leading to strong rev growth and an attractive relative valuation."
Deutsche Bank rated TrueBlue a BUY with a price target of $18.00. TrueBlue closed Wednesday at $13.84.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in